About Bimeda USA
About Bimeda USA
Bimeda US is headquartered in Schaumburg, Illinois, and has four manufacturing facilities in Le Sueur, Minnesota, Irwindale, California, San Angelo, Texas and Kirkland (Seattle) Washington. San Angelo, Texas is home to our Bimeda Biologicals business unit, which is focused on the manufacture of live and inactivated vaccines, as well as diagnostic testing. Kirkland is the home of our aquaculture business, AquaTactics Fish Health. Our research and development facilities in Le Sueur and San Angelo form part of Bimeda’s global innovation program.
USA Headquarters
Oakbrook, Illinois
170+
employees
4 manufacturing
facilities
We have dedicated sales, marketing, customer service and technical teams that are focused on providing the best products and services possible, to meet our customers’ needs.
Our state-of-the art R&D laboratories contribute to our global R&D program, which is committed to anticipating future needs of the animal health sector.
Customer
Service
Sales and
Marketing
R&D
Labs
Bimeda USA Product Range
We offer a comprehensive range of veterinary pharmaceuticals and animal health products for livestock, equine and companion animals as well as bespoke aquaculture products and services. Our range includes joint and cartilage support, anti-parasitics, anti-microbials, hormones, sedatives, anti-inflammatories, vaccines and aquaculture products and services.
Read our corporate brochure to learn more about Bimeda’s global presence
North America Manufacturing and Distribution
North America Manufacturing and Distribution
Globally, Bimeda has ten manufacturing facilities, across seven countries. Five of these are located in the North America.
Le Sueur, Minnesota
Manufacturing Capabilities
Thinking about a career at Bimeda in Le Sueur?
Check out our brochure about life in Le Sueur.
Our facility in Le Sueur, Minnesota is approved to manufacture FDA, EU, and Canadian regulated products. The site offers contract and toll manufacturing and has a wide range of solid dose and non-sterile liquid capabilities.
Solid Dose Capabilities
- Glatt technology granulation
- Tablet coating
- Wide range of available powder, tablet and bolus sizes
- Blister packaging
- Sachet, Jar, Jug, or Box packaging
Non-Sterile Liquid Capabilities
- Explosion-proof manufacturing
- Up to 10,000 L batch size
- Wide range of packaging / container sizes up to 20 L
- Solution and suspension manufacturing
The Le Sueur facility houses a distribution centre with global logistics and an R&D laboratory.
Irwindale, California
Manufacturing Capabilities
The Bimeda Irwindale facility is licensed to manufacture FDA, EU, and Canadian regulated sterile penicillin / beta-lactam products.
Key site features:
- Contract and toll manufacturing
- Powder filling 25 gram and up
San Angelo, Texas
Manufacturing Capabilities
- Production of live and inactivated bovine vaccines to protect against respiratory diseases.
- Production of CL (Caseous Lymphadenitis) vaccine for goats.
Diagnostics
On-site laboratory, which provides diagnostics for antibiotic sensitivity, as well as virus and bacteria isolation and identification.
R&D
On-site R&D laboratory
Vision, Mission and Values
Vision
To be the partner of choice for optimizing the health and wellbeing of the world’s animals.
Mission
We are passionate about providing solutions to help animal lovers and animal health professionals optimize the health and wellbeing of animals around the world.
Values
To succeed in our mission and vision, we are guided in our work by our Bimeda Values. Through our commitment to our Bimeda Values, we are able to continuously drive our business forward and surpass the expectations of our customers each and every day.
Our 5 Core Values
Customer Focus 
Innovation 
Learning 
Collaboration 
Accountability To learn more about Bimeda’s global presence, why not read our corporate brochure.
The Bimeda Story
Bimeda – Driving Excellence in Animal Health For 60 Years!
For 60 years, Bimeda colleagues have been driven by a passion for providing science-driven solutions to optimise the health and wellbeing of animals. If your next career move sees you join Bimeda, you’ll be part of a global network of over colleagues who benefit from 6 decades’ of expertise in animal health, and who are committed to working together to find ever-better ways to exceed the expectations of our customers, as we develop new ways to enhance animal health, welfare and productivity.
But how did we get here? Let’s take a walk down memory lane and look at how Bimeda’s unwavering commitment to animal health has seen us grow from a small Irish enterprise, to a leading global player in the animal health industry.
In The Beginning…..
The original premises of Bimeda Chemicals Ltd in Phibsboro, DublinBimeda Chemicals Limited was founded on 22nd April 1960, when a group of Irish veterinary surgeons set up a company to supply Irish veterinarians with quality veterinary products. The original company motto was ‘For And By The Profession’. As the company founders were themselves veterinarians, they had unrivalled knowledge of the needs and wants of their customer base and were able to develop a highly sought product portfolio.
1963 Advertisement from the Journal of The Veterinary Medical Association of IrelandFrom the original premises in Phibsboro, Dublin, Bimeda Chemicals Ltd manufactured a range of veterinary remedies and also distributed a variety of third party products. As the 1963 advertisement from the Journal of The Veterinary Medical Association of Ireland shows, within just a few years Bimeda had a broad and exciting portfolio of products.
Bimeda quickly gained a reputation for both quality and reliability, and successfully drove awareness of the company’s product range through regular, innovative advertising campaigns. Bimeda’s passion for marketing continues to this day and is supported by our global network of marketing colleagues.
1973 - The Bimeda Acquisition and Expansion into the UK
In 1973 Bimeda Chemicals Limited was acquired by the current Irish owners. The family already owned Osmond & Sons (Dublin) Limited and went on to acquire Constant Chemicals Ltd in 1975. These three companies were subsequently brought together in a new location in Tallaght, Dublin. The new Tallaght facility served for many years as a multi-purpose production and warehousing unit; producing injectables, intramammaries, oral solutions, topicals and hygiene products. By this time, Bimeda had also established itself in the UK market, with a distribution base in Liverpool and a reputation for high quality products.
Expansion into Africa
With Bimeda now firmly established in both Ireland and the UK, ambitions moved towards expansion. The export business became a key strategic focus, with the East African market becoming particularly important.
Despite the challenges of both travel and communication at the time, Bimeda thrived; achieving rapid success in East Africa which has been sustained over many decades. Today Bimeda’s AMEA (Africa, Middle East and Asia) business has a physical presence in Kenya, Zambia, Uganda, Tanzania and China, with an export division which serves the entire AMEA region.
The 1990s - Coming To North America
Throughout the late 1980s and early 1990s Bimeda continued to grow, with a strong network of distributor and contract manufacture partners helping Bimeda products to reach veterinarians and farmers all over Europe and Africa.
However, the company had ambitions beyond the European and AMEA regions and in 1991, Bimeda commenced distributing products in the USA. In 1997, an acquisition followed, giving Bimeda its first permanent base in North America. A period of rapid expansion followed, and between 1997 and 2008, Bimeda undertook 5 key acquisitions in the USA, Canada and Mexico, creating a strong R&D, manufacturing and commercial presence throughout the North American continent.
A Decade of Global Acquisitions
2010 marked the start of a new decade and a period of rapid expansion driven by both organic growth and an ambitious acquisition strategy.
Between 2010 and 2019 Bimeda acquired medicinal, nutritional, diagnostics and vaccine businesses in Kenya, Brazil, the UK, US and France, as well as acquiring the veterinary medicine portfolio of Grupo Unipharm in Central America.
-
2011
Acquired
- Assia (Kenya)
- Mogivet (Brazil)
-
2012
Acquired
- Vetpharm Limited
(UK-based exports company)
- Vetpharm Limited
-
2013
Acquired
- Telsol Limited
(UK bolus technology)
- Telsol Limited
-
2014
Acquired
- Zootech (France)
-
2016
Acquired
- ArthroDynamic Technology Inc.
(Equine product specialist, USA) - NBVC (Nutrition, France)
- Iodolab (Diagnostics, France)
- ArthroDynamic Technology Inc.
-
2019
Acquired
- Veterinary Medicine Portfolio of Grupo Unipharm (Central America)
- Texas Vet Lab, Inc (USA)
(Vaccine manufacture and diagnostics)
-
2020
New Identity
- Texas Vet Lab Inc becomes Bimeda Biologicals
-
2021
Acquired
- AquaTactics Fish Health (USA)
-
2022
Acquired
- Afrivet Southern Africa Proprietary Limited (South Africa)
-
2023
Philanthropy
- UCD Bimeda Herd Health Hub & AgTechUCD Innovation Centre
Bimeda philanthropic donation
- UCD Bimeda Herd Health Hub & AgTechUCD Innovation Centre
During this period, Bimeda also joined Rainbow Laboratories Ltd, in establishing a raw material testing and innovation centre in Shijiazhuang, China.
2019 also saw the opening of Bimeda’s Global Innovation Centre in Dublin, Ireland, which leads our global innovation programme, in collaboration with five additional R&D laboratories in Minnesota (USA), Texas (USA), Monet Mor (Brazil), Shiazhuang (China) and Cambridge (Canada).
2020 and Beyond
Bimeda China Shijiazhuang FacilityIn 2020, our state-of-the art sterile injectable manufacturing facility located in Shijiazhuang, China proudly commenced manufacturing operations. The facility is approved to supply quality veterinary pharmaceutical products to China, Australia, New Zealand, Kenya and Uganda.
In 2021, Bimeda was pleased to enter the aquaculture sector, with the acquisition of AquaTactics Fish Health, in the USA. The same year, Bimeda established a new greenfield organisation in Denmark, Bimeda Nordic Aps. From early 2022 Bimeda Nordic commenced supply of our broad range of veterinary pharmaceuticals and animal health products to the Nordic region.
In 2022 Bimeda acquired Afrivet Limited in South Africa, resulting in Bimeda having the largest footprint of any animal health company in Africa.
In 2023 Bimeda made a substantial philanthropic donation to the UCD Foundation in Ireland. This donation was used to help fund the UCD Bimeda Herd Health Hub and AgTechUD Innovation Centre at UCD Lyons Farm in county Kildare, Ireland.
Today Bimeda employs over people worldwide and has a presence in over 80 countries. Our 11 manufacturing and 8 R&D facilities all operate to the highest regulatory standards, and our global supply chain and distribution network sees our products used to enhance animal health in all major food-producing regions.
Bimeda is an organisation which will continue to grow, continue to invest in innovation and continue to be committed to finding ever-better ways to serve our customer, as we continue strive for global excellence in animal health.
If you would like to join us on our exciting journey, check out our current vacancies.